a trend towards significanceP = 0.055
Cardiovascular adverse events The incidence of cardiovascular AEs was low overall but was numerically higher in the oral diclofenac group, showing a trend towards significance (3.5% vs 1.5%, P = 0.055).
Cardiovascular adverse events The incidence of cardiovascular AEs was low overall but was numerically higher in the oral diclofenac group, showing a trend towards significance (3.5% vs 1.5%, P = 0.055).